Abbvie Stock Forecast

Buy or Hold candidate since Jun 03, 2026 Gain 8.18%

The AbbVie stock price gained 0.0554% on the last trading day (Wednesday, 24th Jun 2026), rising from $234.76 to $234.89. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.92% from a day low at $232.85 to a day high of $237.33. The price has been going up and down for this period, and there has been a 4.2% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 82 thousand more shares were traded than the day before. In total, 7 million shares were bought and sold for approximately $1.71 billion.

The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $236.58 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 9.47% during the next 3 months and, with a 90% probability hold a price between $230.52 and $258.98 at the end of this 3-month period.

ABBV Signals & Forecast

The AbbVie stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $225.95 and $216.90. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 8.43%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for AbbVie stock

On the downside, the stock finds support just below today's level from accumulated volume at $211.33 and $206.47. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AbbVie finds support just below today's level at $211.33. If this is broken, then the next support from accumulated volume will be at $206.47 and $204.35.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $4.48 between high and low, or 1.92%. For the last week, the stock has had daily average volatility of 2.68%.

Our recommended stop-loss: $226.29 (-3.66%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (ABBV) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect AbbVie Inc to open at $235.02, and during the day (based on 14 day Average True Range), to move between $231.92 and $237.86, which gives a possible trading interval of +/-$5.94 (+/-2.56%) up or down from last closing price. If AbbVie Inc takes out the full calculated possible swing range there will be an estimated 2.56% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $211.33, some $23.56 (10.03%) from the current price of $234.89, our system finds the risk reward attractive.

Dividend Warning For ABBV

Dividend coming up for ABBV: Ex-dividend date (Wednesday 15th July, 2026) is 19 days away. The dividend is $1.73.

Is AbbVie Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for AbbVie stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 4.376 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 25, 2026 - $235.02 ( 0.0568%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk